
    
      Patients with the diagnosis of migraine according to the International Headache Society (IHS)
      criteria were enrolled in the study during a migraine attack. Patients received two 200 mg
      capsules of dry ginger extract (5% active ingredient) or two capsules of placebo (cellulose)
      in addition to an intravenous dose of ketoprofen (100 milligrams - mg) to treat the migraine
      attack.
    
  